{"transactions":[{"id":712628,"issuer":{"id":3538,"kind":"organization","name":"Praxis Precision Medicines, Inc."},"owners":[{"id":31447,"kind":"person","name":"Souza Marcio","position":1,"cik":"0001707657","reported_name":"Souza Marcio","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Common Stock","published_at":"2026-07-08T20:56:04.000Z","date":"2026-07-08","kind":"gift","planned":false,"acquired":false,"shares":2600,"price":0,"value":0.0,"ownership":{"direct":false,"nature":"Held by spouse"},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"This transaction represents a bona fide gift of common stock to the Souza 2026 Trust."}],"balance_after":0,"source":{"system":"sec-edgar","filing":"0001707657-26-000008","document":"wk-form4_1783544160.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1707657/000170765726000008/wk-form4_1783544160.xml","form_type":"4"}},{"id":712627,"issuer":{"id":3538,"kind":"organization","name":"Praxis Precision Medicines, Inc."},"owners":[{"id":31447,"kind":"person","name":"Souza Marcio","position":1,"cik":"0001707657","reported_name":"Souza Marcio","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Common Stock","published_at":"2026-07-08T20:56:04.000Z","date":"2026-07-08","kind":"gift","planned":false,"acquired":false,"shares":20521,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"This transaction represents a bona fide gift of common stock to the Souza 2026 Trust."}],"balance_after":56495,"source":{"system":"sec-edgar","filing":"0001707657-26-000008","document":"wk-form4_1783544160.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1707657/000170765726000008/wk-form4_1783544160.xml","form_type":"4"}},{"id":725507,"issuer":{"id":3538,"kind":"organization","name":"Praxis Precision Medicines, Inc."},"owners":[{"id":35155,"kind":"person","name":"DeSimone Jill","position":1,"cik":"0001930479","reported_name":"DeSimone Jill","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2026-06-26T21:09:23.000Z","date":"2026-06-24","kind":"exercise","planned":true,"acquired":false,"shares":3034,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F14","text":"This option was fully vested as of May 23, 2025."}],"balance_after":0,"derivative":{"exercise_price":147.3,"expiration_date":"2032-05-23","underlying":"Common Stock","underlying_shares":3034},"source":{"system":"sec-edgar","filing":"0001930479-26-000003","document":"wk-form4_1782508155.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":16,"url":"https://www.sec.gov/Archives/edgar/data/1689548/000193047926000003/wk-form4_1782508155.xml","form_type":"4"}},{"id":725506,"issuer":{"id":3538,"kind":"organization","name":"Praxis Precision Medicines, Inc."},"owners":[{"id":35155,"kind":"person","name":"DeSimone Jill","position":1,"cik":"0001930479","reported_name":"DeSimone Jill","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2026-06-26T21:09:23.000Z","date":"2026-06-24","kind":"exercise","planned":true,"acquired":false,"shares":8566,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F13","text":"This option was fully vested as of June 5, 2025."}],"balance_after":0,"derivative":{"exercise_price":44.25,"expiration_date":"2034-06-05","underlying":"Common Stock","underlying_shares":8566},"source":{"system":"sec-edgar","filing":"0001930479-26-000003","document":"wk-form4_1782508155.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":15,"url":"https://www.sec.gov/Archives/edgar/data/1689548/000193047926000003/wk-form4_1782508155.xml","form_type":"4"}},{"id":725505,"issuer":{"id":3538,"kind":"organization","name":"Praxis Precision Medicines, Inc."},"owners":[{"id":35155,"kind":"person","name":"DeSimone Jill","position":1,"cik":"0001930479","reported_name":"DeSimone Jill","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2026-06-26T21:09:23.000Z","date":"2026-06-24","kind":"sale","planned":true,"acquired":false,"shares":837,"price":315.705,"value":264245.085,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted on March 25, 2026."},{"field":"price","element":"transactionPricePerShare","label":"F12","text":"The price reported is a weighted average price. The securities were sold in multiple transactions at per share prices ranging from $315.590 to $316.010. The Reporting Person undertakes to provide upon request from the SEC staff, the Issuer, or any shareholder of the Issuer, full information regarding the number of securities sold at each separate price within the range set forth in this footnote."}],"balance_after":2337,"source":{"system":"sec-edgar","filing":"0001930479-26-000003","document":"wk-form4_1782508155.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":14,"url":"https://www.sec.gov/Archives/edgar/data/1689548/000193047926000003/wk-form4_1782508155.xml","form_type":"4"}},{"id":725504,"issuer":{"id":3538,"kind":"organization","name":"Praxis Precision Medicines, Inc."},"owners":[{"id":35155,"kind":"person","name":"DeSimone Jill","position":1,"cik":"0001930479","reported_name":"DeSimone Jill","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2026-06-26T21:09:23.000Z","date":"2026-06-24","kind":"sale","planned":true,"acquired":false,"shares":1279,"price":314.901,"value":402758.379,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted on March 25, 2026."},{"field":"price","element":"transactionPricePerShare","label":"F11","text":"The price reported is a weighted average price. The securities were sold in multiple transactions at per share prices ranging from $314.400 to $315.380. The Reporting Person undertakes to provide upon request from the SEC staff, the Issuer, or any shareholder of the Issuer, full information regarding the number of securities sold at each separate price within the range set forth in this footnote."}],"balance_after":3174,"source":{"system":"sec-edgar","filing":"0001930479-26-000003","document":"wk-form4_1782508155.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":13,"url":"https://www.sec.gov/Archives/edgar/data/1689548/000193047926000003/wk-form4_1782508155.xml","form_type":"4"}},{"id":725503,"issuer":{"id":3538,"kind":"organization","name":"Praxis Precision Medicines, Inc."},"owners":[{"id":35155,"kind":"person","name":"DeSimone Jill","position":1,"cik":"0001930479","reported_name":"DeSimone Jill","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2026-06-26T21:09:23.000Z","date":"2026-06-24","kind":"sale","planned":true,"acquired":false,"shares":504,"price":313.663,"value":158086.152,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted on March 25, 2026."},{"field":"price","element":"transactionPricePerShare","label":"F10","text":"The price reported is a weighted average price. The securities were sold in multiple transactions at per share prices ranging from $313.400 to $314.000. The Reporting Person undertakes to provide upon request from the SEC staff, the Issuer, or any shareholder of the Issuer, full information regarding the number of securities sold at each separate price within the range set forth in this footnote."}],"balance_after":4453,"source":{"system":"sec-edgar","filing":"0001930479-26-000003","document":"wk-form4_1782508155.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":12,"url":"https://www.sec.gov/Archives/edgar/data/1689548/000193047926000003/wk-form4_1782508155.xml","form_type":"4"}},{"id":725502,"issuer":{"id":3538,"kind":"organization","name":"Praxis Precision Medicines, Inc."},"owners":[{"id":35155,"kind":"person","name":"DeSimone Jill","position":1,"cik":"0001930479","reported_name":"DeSimone Jill","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2026-06-26T21:09:23.000Z","date":"2026-06-24","kind":"sale","planned":true,"acquired":false,"shares":1004,"price":312.83,"value":314081.32,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted on March 25, 2026."},{"field":"price","element":"transactionPricePerShare","label":"F9","text":"The price reported is a weighted average price. The securities were sold in multiple transactions at per share prices ranging from $312.370 to $313.280. The Reporting Person undertakes to provide upon request from the SEC staff, the Issuer, or any shareholder of the Issuer, full information regarding the number of securities sold at each separate price within the range set forth in this footnote."}],"balance_after":4957,"source":{"system":"sec-edgar","filing":"0001930479-26-000003","document":"wk-form4_1782508155.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":11,"url":"https://www.sec.gov/Archives/edgar/data/1689548/000193047926000003/wk-form4_1782508155.xml","form_type":"4"}},{"id":725501,"issuer":{"id":3538,"kind":"organization","name":"Praxis Precision Medicines, Inc."},"owners":[{"id":35155,"kind":"person","name":"DeSimone Jill","position":1,"cik":"0001930479","reported_name":"DeSimone Jill","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2026-06-26T21:09:23.000Z","date":"2026-06-24","kind":"sale","planned":true,"acquired":false,"shares":2854,"price":311.914,"value":890202.556,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted on March 25, 2026."},{"field":"price","element":"transactionPricePerShare","label":"F8","text":"The price reported is a weighted average price. The securities were sold in multiple transactions at per share prices ranging from $311.340 to $312.320. The Reporting Person undertakes to provide upon request from the SEC staff, the Issuer, or any shareholder of the Issuer, full information regarding the number of securities sold at each separate price within the range set forth in this footnote."}],"balance_after":5961,"source":{"system":"sec-edgar","filing":"0001930479-26-000003","document":"wk-form4_1782508155.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":10,"url":"https://www.sec.gov/Archives/edgar/data/1689548/000193047926000003/wk-form4_1782508155.xml","form_type":"4"}},{"id":725500,"issuer":{"id":3538,"kind":"organization","name":"Praxis Precision Medicines, Inc."},"owners":[{"id":35155,"kind":"person","name":"DeSimone Jill","position":1,"cik":"0001930479","reported_name":"DeSimone Jill","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2026-06-26T21:09:23.000Z","date":"2026-06-24","kind":"sale","planned":true,"acquired":false,"shares":1750,"price":310.889,"value":544055.75,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted on March 25, 2026."},{"field":"price","element":"transactionPricePerShare","label":"F7","text":"The price reported is a weighted average price. The securities were sold in multiple transactions at per share prices ranging from $310.340 to $311.300. The Reporting Person undertakes to provide upon request from the SEC staff, the Issuer, or any shareholder of the Issuer, full information regarding the number of securities sold at each separate price within the range set forth in this footnote."}],"balance_after":8815,"source":{"system":"sec-edgar","filing":"0001930479-26-000003","document":"wk-form4_1782508155.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":9,"url":"https://www.sec.gov/Archives/edgar/data/1689548/000193047926000003/wk-form4_1782508155.xml","form_type":"4"}},{"id":725499,"issuer":{"id":3538,"kind":"organization","name":"Praxis Precision Medicines, Inc."},"owners":[{"id":35155,"kind":"person","name":"DeSimone Jill","position":1,"cik":"0001930479","reported_name":"DeSimone Jill","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2026-06-26T21:09:23.000Z","date":"2026-06-24","kind":"sale","planned":true,"acquired":false,"shares":999,"price":309.383,"value":309073.617,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted on March 25, 2026."},{"field":"price","element":"transactionPricePerShare","label":"F6","text":"The price reported is a weighted average price. The securities were sold in multiple transactions at per share prices ranging from $308.900 to $309.790. The Reporting Person undertakes to provide upon request from the SEC staff, the Issuer, or any shareholder of the Issuer, full information regarding the number of securities sold at each separate price within the range set forth in this footnote."}],"balance_after":10565,"source":{"system":"sec-edgar","filing":"0001930479-26-000003","document":"wk-form4_1782508155.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":8,"url":"https://www.sec.gov/Archives/edgar/data/1689548/000193047926000003/wk-form4_1782508155.xml","form_type":"4"}},{"id":725498,"issuer":{"id":3538,"kind":"organization","name":"Praxis Precision Medicines, Inc."},"owners":[{"id":35155,"kind":"person","name":"DeSimone Jill","position":1,"cik":"0001930479","reported_name":"DeSimone Jill","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2026-06-26T21:09:23.000Z","date":"2026-06-24","kind":"sale","planned":true,"acquired":false,"shares":1240,"price":308.243,"value":382221.32,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted on March 25, 2026."},{"field":"price","element":"transactionPricePerShare","label":"F5","text":"The price reported is a weighted average price. The securities were sold in multiple transactions at per share prices ranging from $307.900 to $308.870. The Reporting Person undertakes to provide upon request from the SEC staff, the Issuer, or any shareholder of the Issuer, full information regarding the number of securities sold at each separate price within the range set forth in this footnote."}],"balance_after":11564,"source":{"system":"sec-edgar","filing":"0001930479-26-000003","document":"wk-form4_1782508155.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":7,"url":"https://www.sec.gov/Archives/edgar/data/1689548/000193047926000003/wk-form4_1782508155.xml","form_type":"4"}},{"id":725497,"issuer":{"id":3538,"kind":"organization","name":"Praxis Precision Medicines, Inc."},"owners":[{"id":35155,"kind":"person","name":"DeSimone Jill","position":1,"cik":"0001930479","reported_name":"DeSimone Jill","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2026-06-26T21:09:23.000Z","date":"2026-06-24","kind":"sale","planned":true,"acquired":false,"shares":683,"price":306.767,"value":209521.861,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted on March 25, 2026."},{"field":"price","element":"transactionPricePerShare","label":"F4","text":"The price reported is a weighted average price. The securities were sold in multiple transactions at per share prices ranging from $306.365 to $307.180. The Reporting Person undertakes to provide upon request from the SEC staff, the Issuer, or any shareholder of the Issuer, full information regarding the number of securities sold at each separate price within the range set forth in this footnote."}],"balance_after":12804,"source":{"system":"sec-edgar","filing":"0001930479-26-000003","document":"wk-form4_1782508155.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":6,"url":"https://www.sec.gov/Archives/edgar/data/1689548/000193047926000003/wk-form4_1782508155.xml","form_type":"4"}},{"id":725496,"issuer":{"id":3538,"kind":"organization","name":"Praxis Precision Medicines, Inc."},"owners":[{"id":35155,"kind":"person","name":"DeSimone Jill","position":1,"cik":"0001930479","reported_name":"DeSimone Jill","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2026-06-26T21:09:23.000Z","date":"2026-06-24","kind":"sale","planned":true,"acquired":false,"shares":320,"price":305.31,"value":97699.2,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted on March 25, 2026."},{"field":"price","element":"transactionPricePerShare","label":"F3","text":"The price reported is a weighted average price. The securities were sold in multiple transactions at per share prices ranging from $305.000 to $305.830. The Reporting Person undertakes to provide upon request from the SEC staff, the Issuer, or any shareholder of the Issuer, full information regarding the number of securities sold at each separate price within the range set forth in this footnote."}],"balance_after":13487,"source":{"system":"sec-edgar","filing":"0001930479-26-000003","document":"wk-form4_1782508155.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/1689548/000193047926000003/wk-form4_1782508155.xml","form_type":"4"}},{"id":725495,"issuer":{"id":3538,"kind":"organization","name":"Praxis Precision Medicines, Inc."},"owners":[{"id":35155,"kind":"person","name":"DeSimone Jill","position":1,"cik":"0001930479","reported_name":"DeSimone Jill","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2026-06-26T21:09:23.000Z","date":"2026-06-24","kind":"sale","planned":true,"acquired":false,"shares":120,"price":303.127,"value":36375.24,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted on March 25, 2026."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The price reported is a weighted average price. The securities were sold in multiple transactions at per share prices ranging from $302.500 to $303.440. The Reporting Person undertakes to provide upon request from the SEC staff, the Issuer, or any shareholder of the Issuer, full information regarding the number of securities sold at each separate price within the range set forth in this footnote."}],"balance_after":13807,"source":{"system":"sec-edgar","filing":"0001930479-26-000003","document":"wk-form4_1782508155.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1689548/000193047926000003/wk-form4_1782508155.xml","form_type":"4"}},{"id":725494,"issuer":{"id":3538,"kind":"organization","name":"Praxis Precision Medicines, Inc."},"owners":[{"id":35155,"kind":"person","name":"DeSimone Jill","position":1,"cik":"0001930479","reported_name":"DeSimone Jill","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2026-06-26T21:09:23.000Z","date":"2026-06-24","kind":"sale","planned":true,"acquired":false,"shares":10,"price":301.44,"value":3014.4,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted on March 25, 2026."}],"balance_after":13927,"source":{"system":"sec-edgar","filing":"0001930479-26-000003","document":"wk-form4_1782508155.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1689548/000193047926000003/wk-form4_1782508155.xml","form_type":"4"}},{"id":725493,"issuer":{"id":3538,"kind":"organization","name":"Praxis Precision Medicines, Inc."},"owners":[{"id":35155,"kind":"person","name":"DeSimone Jill","position":1,"cik":"0001930479","reported_name":"DeSimone Jill","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2026-06-26T21:09:23.000Z","date":"2026-06-24","kind":"exercise","planned":true,"acquired":true,"shares":3034,"price":147.3,"value":446908.2,"ownership":{"direct":true},"balance_after":13937,"source":{"system":"sec-edgar","filing":"0001930479-26-000003","document":"wk-form4_1782508155.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1689548/000193047926000003/wk-form4_1782508155.xml","form_type":"4"}},{"id":725492,"issuer":{"id":3538,"kind":"organization","name":"Praxis Precision Medicines, Inc."},"owners":[{"id":35155,"kind":"person","name":"DeSimone Jill","position":1,"cik":"0001930479","reported_name":"DeSimone Jill","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2026-06-26T21:09:23.000Z","date":"2026-06-24","kind":"exercise","planned":true,"acquired":true,"shares":8566,"price":44.25,"value":379045.5,"ownership":{"direct":true},"balance_after":10903,"source":{"system":"sec-edgar","filing":"0001930479-26-000003","document":"wk-form4_1782508155.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1689548/000193047926000003/wk-form4_1782508155.xml","form_type":"4"}},{"id":739842,"issuer":{"id":3538,"kind":"organization","name":"Praxis Precision Medicines, Inc."},"owners":[{"id":15072,"kind":"person","name":"Arbuckle Stuart A","position":1,"cik":"0001557290","reported_name":"Arbuckle Stuart A","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2026-06-12T21:24:26.000Z","date":"2026-06-10","kind":"grant","planned":false,"acquired":true,"shares":648,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The shares subject to this option shall vest in twelve (12) equal monthly installments occurring on the 10th day of each month, with the first such installment occurring on July 10, 2026 and the final such installment occurring on the earlier of (i) June 10, 2027 or (ii) the date of the Issuer's 2027 annual meeting of stockholders."}],"balance_after":648,"derivative":{"exercise_price":240.66,"expiration_date":"2036-06-10","underlying":"Common Stock","underlying_shares":648},"source":{"system":"sec-edgar","filing":"0001689548-26-000064","document":"wk-form4_1781299464.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1689548/000168954826000064/wk-form4_1781299464.xml","form_type":"4"}},{"id":739841,"issuer":{"id":3538,"kind":"organization","name":"Praxis Precision Medicines, Inc."},"owners":[{"id":15072,"kind":"person","name":"Arbuckle Stuart A","position":1,"cik":"0001557290","reported_name":"Arbuckle Stuart A","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2026-06-12T21:24:26.000Z","date":"2026-06-10","kind":"grant","planned":false,"acquired":true,"shares":1371,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Mr. Arbuckle was awarded 1,371 restricted stock units. Each restricted stock unit represents a contingent right to receive one share of the Issuer's common stock. The restricted stock units vest in a single annual installment on the earlier of (i) June 10, 2027 or (ii) the date of the Issuer's 2027 annual meeting of stockholders. The restricted stock units may be settled only by delivering shares of the Issuer's common stock, and thus, the grant is being reported in Table 1 as allowed per SEC guidance."}],"balance_after":2537,"source":{"system":"sec-edgar","filing":"0001689548-26-000064","document":"wk-form4_1781299464.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1689548/000168954826000064/wk-form4_1781299464.xml","form_type":"4"}},{"id":739840,"issuer":{"id":3538,"kind":"organization","name":"Praxis Precision Medicines, Inc."},"owners":[{"id":16105,"kind":"person","name":"Chodakewitz Jeffrey","position":1,"cik":"0001610876","reported_name":"Chodakewitz Jeffrey","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2026-06-12T21:24:20.000Z","date":"2026-06-10","kind":"grant","planned":false,"acquired":true,"shares":648,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The shares subject to this option shall vest in twelve (12) equal monthly installments occurring on the 10th day of each month, with the first such installment occurring on July 10, 2026 and the final such installment occurring on the earlier of (i) June 10, 2027 or (ii) the date of the Issuer's 2027 annual meeting of stockholders."}],"balance_after":648,"derivative":{"exercise_price":240.66,"expiration_date":"2036-06-10","underlying":"Common Stock","underlying_shares":648},"source":{"system":"sec-edgar","filing":"0001689548-26-000063","document":"wk-form4_1781299458.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1689548/000168954826000063/wk-form4_1781299458.xml","form_type":"4"}},{"id":739839,"issuer":{"id":3538,"kind":"organization","name":"Praxis Precision Medicines, Inc."},"owners":[{"id":16105,"kind":"person","name":"Chodakewitz Jeffrey","position":1,"cik":"0001610876","reported_name":"Chodakewitz Jeffrey","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2026-06-12T21:24:20.000Z","date":"2026-06-10","kind":"grant","planned":false,"acquired":true,"shares":1371,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Dr. Chodakewitz was awarded 1,371 restricted stock units. Each restricted stock unit represents a contingent right to receive one share of the Issuer's common stock. The restricted stock units vest in a single annual installment on the earlier of (i) June 10, 2027 or (ii) the date of the Issuer's 2027 annual meeting of stockholders. The restricted stock units may be settled only by delivering shares of the Issuer's common stock, and thus, the grant is being reported in Table 1 as allowed per SEC guidance."}],"balance_after":1371,"source":{"system":"sec-edgar","filing":"0001689548-26-000063","document":"wk-form4_1781299458.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1689548/000168954826000063/wk-form4_1781299458.xml","form_type":"4"}},{"id":739838,"issuer":{"id":3538,"kind":"organization","name":"Praxis Precision Medicines, Inc."},"owners":[{"id":15813,"kind":"person","name":"YOUNG WILLIAM D","position":1,"cik":"0001217420","reported_name":"YOUNG WILLIAM D","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2026-06-12T21:24:15.000Z","date":"2026-06-10","kind":"grant","planned":false,"acquired":true,"shares":648,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The shares subject to this option shall vest in twelve (12) equal monthly installments occurring on the 10th day of each month, with the first such installment occurring on July 10, 2026 and the final such installment occurring on the earlier of (i) June 10, 2027 or (ii) the date of the Issuer's 2027 annual meeting of stockholders."}],"balance_after":648,"derivative":{"exercise_price":240.66,"expiration_date":"2036-06-10","underlying":"Common Stock","underlying_shares":648},"source":{"system":"sec-edgar","filing":"0001689548-26-000062","document":"wk-form4_1781299452.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1689548/000168954826000062/wk-form4_1781299452.xml","form_type":"4"}},{"id":739837,"issuer":{"id":3538,"kind":"organization","name":"Praxis Precision Medicines, Inc."},"owners":[{"id":15813,"kind":"person","name":"YOUNG WILLIAM D","position":1,"cik":"0001217420","reported_name":"YOUNG WILLIAM D","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2026-06-12T21:24:15.000Z","date":"2026-06-10","kind":"grant","planned":false,"acquired":true,"shares":1371,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Mr. Young was awarded 1,371 restricted stock units. Each restricted stock unit represents a contingent right to receive one share of the Issuer's common stock. The restricted stock units vest in a single annual installment on the earlier of (i) June 10, 2027 or (ii) the date of the Issuer's 2027 annual meeting of stockholders. The restricted stock units may be settled only by delivering shares of the Issuer's common stock, and thus, the grant is being reported in Table 1 as allowed per SEC guidance."}],"balance_after":3269,"source":{"system":"sec-edgar","filing":"0001689548-26-000062","document":"wk-form4_1781299452.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1689548/000168954826000062/wk-form4_1781299452.xml","form_type":"4"}},{"id":739836,"issuer":{"id":3538,"kind":"organization","name":"Praxis Precision Medicines, Inc."},"owners":[{"id":35155,"kind":"person","name":"DeSimone Jill","position":1,"cik":"0001930479","reported_name":"DeSimone Jill","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2026-06-12T21:24:09.000Z","date":"2026-06-10","kind":"grant","planned":false,"acquired":true,"shares":648,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The shares subject to this option shall vest in twelve (12) equal monthly installments occurring on the 10th day of each month, with the first such installment occurring on July 10, 2026 and the final such installment occurring on the earlier of (i) June 10, 2027 or (ii) the date of the Issuer's 2027 annual meeting of stockholders."}],"balance_after":648,"derivative":{"exercise_price":240.66,"expiration_date":"2036-06-10","underlying":"Common Stock","underlying_shares":648},"source":{"system":"sec-edgar","filing":"0001689548-26-000061","document":"wk-form4_1781299446.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1689548/000168954826000061/wk-form4_1781299446.xml","form_type":"4"}},{"id":739835,"issuer":{"id":3538,"kind":"organization","name":"Praxis Precision Medicines, Inc."},"owners":[{"id":35155,"kind":"person","name":"DeSimone Jill","position":1,"cik":"0001930479","reported_name":"DeSimone Jill","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2026-06-12T21:24:09.000Z","date":"2026-06-10","kind":"grant","planned":false,"acquired":true,"shares":1371,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Ms. DeSimone was awarded 1,371 restricted stock units. Each restricted stock unit represents a contingent right to receive one share of the Issuer's common stock. The restricted stock units vest in a single annual installment on the earlier of (i) June 10, 2027 or (ii) the date of the Issuer's 2027 annual meeting of stockholders. The restricted stock units may be settled only by delivering shares of the Issuer's common stock, and thus, the grant is being reported in Table 1 as allowed per SEC guidance."}],"balance_after":2337,"source":{"system":"sec-edgar","filing":"0001689548-26-000061","document":"wk-form4_1781299446.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1689548/000168954826000061/wk-form4_1781299446.xml","form_type":"4"}},{"id":739834,"issuer":{"id":3538,"kind":"organization","name":"Praxis Precision Medicines, Inc."},"owners":[{"id":38737,"kind":"person","name":"Cudkowicz Merit Ester","position":1,"cik":"0001856299","reported_name":"Cudkowicz Merit Ester","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2026-06-12T21:24:03.000Z","date":"2026-06-10","kind":"grant","planned":false,"acquired":true,"shares":648,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The shares subject to this option shall vest in twelve (12) equal monthly installments occurring on the 10th day of each month, with the first such installment occurring on July 10, 2026 and the final such installment occurring on the earlier of (i) June 10, 2027 or (ii) the date of the Issuer's 2027 annual meeting of stockholders."}],"balance_after":648,"derivative":{"exercise_price":240.66,"expiration_date":"2036-06-10","underlying":"Common Stock","underlying_shares":648},"source":{"system":"sec-edgar","filing":"0001689548-26-000060","document":"wk-form4_1781299441.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1689548/000168954826000060/wk-form4_1781299441.xml","form_type":"4"}},{"id":739833,"issuer":{"id":3538,"kind":"organization","name":"Praxis Precision Medicines, Inc."},"owners":[{"id":38737,"kind":"person","name":"Cudkowicz Merit Ester","position":1,"cik":"0001856299","reported_name":"Cudkowicz Merit Ester","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2026-06-12T21:24:03.000Z","date":"2026-06-10","kind":"grant","planned":false,"acquired":true,"shares":1371,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Dr. Cudkowicz was awarded 1,371 restricted stock units. Each restricted stock unit represents a contingent right to receive one share of the Issuer's common stock. The restricted stock units vest in a single annual installment on the earlier of (i) June 10, 2027 or (ii) the date of the Issuer's 2027 annual meeting of stockholders. The restricted stock units may be settled only by delivering shares of the Issuer's common stock, and thus, the grant is being reported in Table 1 as allowed per SEC guidance."}],"balance_after":1371,"source":{"system":"sec-edgar","filing":"0001689548-26-000060","document":"wk-form4_1781299441.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1689548/000168954826000060/wk-form4_1781299441.xml","form_type":"4"}},{"id":739832,"issuer":{"id":3538,"kind":"organization","name":"Praxis Precision Medicines, Inc."},"owners":[{"id":17741,"kind":"person","name":"MITCHELL DEAN J","position":1,"cik":"0001199297","reported_name":"MITCHELL DEAN J","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2026-06-12T21:23:57.000Z","date":"2026-06-10","kind":"grant","planned":false,"acquired":true,"shares":648,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The shares subject to this option shall vest in twelve (12) equal monthly installments occurring on the 10th day of each month, with the first such installment occurring on July 10, 2026 and the final such installment occurring on the earlier of (i) June 10, 2027 or (ii) the date of the Issuer's 2027 annual meeting of stockholders."}],"balance_after":648,"derivative":{"exercise_price":240.66,"expiration_date":"2036-06-10","underlying":"Common Stock","underlying_shares":648},"source":{"system":"sec-edgar","filing":"0001689548-26-000059","document":"wk-form4_1781299435.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1689548/000168954826000059/wk-form4_1781299435.xml","form_type":"4"}},{"id":739831,"issuer":{"id":3538,"kind":"organization","name":"Praxis Precision Medicines, Inc."},"owners":[{"id":17741,"kind":"person","name":"MITCHELL DEAN J","position":1,"cik":"0001199297","reported_name":"MITCHELL DEAN J","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2026-06-12T21:23:57.000Z","date":"2026-06-10","kind":"grant","planned":false,"acquired":true,"shares":1371,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Mr. Mitchell was awarded 1,371 restricted stock units. Each restricted stock unit represents a contingent right to receive one share of the Issuer's common stock. The restricted stock units vest in a single annual installment on the earlier of (i) June 10, 2027 or (ii) the date of the Issuer's 2027 annual meeting of stockholders. The restricted stock units may be settled only by delivering shares of the Issuer's common stock, and thus, the grant is being reported in Table 1 as allowed per SEC guidance."}],"balance_after":18622,"source":{"system":"sec-edgar","filing":"0001689548-26-000059","document":"wk-form4_1781299435.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1689548/000168954826000059/wk-form4_1781299435.xml","form_type":"4"}},{"id":740360,"issuer":{"id":3538,"kind":"organization","name":"Praxis Precision Medicines, Inc."},"owners":[{"id":16924,"kind":"person","name":"KINDLER JEFFREY B","position":1,"cik":"0001174454","reported_name":"KINDLER JEFFREY B","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2026-06-12T21:23:52.000Z","date":"2026-06-10","kind":"grant","planned":false,"acquired":true,"shares":648,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The shares subject to this option shall vest in twelve (12) equal monthly installments occurring on the 10th day of each month, with the first such installment occurring on July 10, 2026 and the final such installment occurring on the earlier of (i) June 10, 2027 or (ii) the date of the Issuer's 2027 annual meeting of stockholders."}],"balance_after":648,"derivative":{"exercise_price":240.66,"expiration_date":"2036-06-10","underlying":"Common Stock","underlying_shares":648},"source":{"system":"sec-edgar","filing":"0001689548-26-000058","document":"wk-form4_1781299429.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1174454/000168954826000058/wk-form4_1781299429.xml","form_type":"4"}},{"id":740359,"issuer":{"id":3538,"kind":"organization","name":"Praxis Precision Medicines, Inc."},"owners":[{"id":16924,"kind":"person","name":"KINDLER JEFFREY B","position":1,"cik":"0001174454","reported_name":"KINDLER JEFFREY B","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2026-06-12T21:23:52.000Z","date":"2026-06-10","kind":"grant","planned":false,"acquired":true,"shares":1371,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Mr. Kindler was awarded 1,371 restricted stock units. Each restricted stock unit represents a contingent right to receive one share of the Issuer's common stock. The restricted stock units vest in a single annual installment on the earlier of (i) June 10, 2027 or (ii) the date of the Issuer's 2027 annual meeting of stockholders. The restricted stock units may be settled only by delivering shares of the Issuer's common stock, and thus, the grant is being reported in Table 1 as allowed per SEC guidance."}],"balance_after":2537,"source":{"system":"sec-edgar","filing":"0001689548-26-000058","document":"wk-form4_1781299429.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1174454/000168954826000058/wk-form4_1781299429.xml","form_type":"4"}},{"id":739829,"issuer":{"id":3538,"kind":"organization","name":"Praxis Precision Medicines, Inc."},"owners":[{"id":38736,"kind":"person","name":"Norden Gregory","position":1,"cik":"0001405104","reported_name":"Norden Gregory","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2026-06-12T21:23:45.000Z","date":"2026-06-10","kind":"grant","planned":false,"acquired":true,"shares":648,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The shares subject to this option shall vest in twelve (12) equal monthly installments occurring on the 10th day of each month, with the first such installment occurring on July 10, 2026 and the final such installment occurring on the earlier of (i) June 10, 2027 or (ii) the date of the Issuer's 2027 annual meeting of stockholders."}],"balance_after":648,"derivative":{"exercise_price":240.66,"expiration_date":"2036-06-10","underlying":"Common Stock","underlying_shares":648},"source":{"system":"sec-edgar","filing":"0001689548-26-000057","document":"wk-form4_1781299421.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1689548/000168954826000057/wk-form4_1781299421.xml","form_type":"4"}},{"id":739828,"issuer":{"id":3538,"kind":"organization","name":"Praxis Precision Medicines, Inc."},"owners":[{"id":38736,"kind":"person","name":"Norden Gregory","position":1,"cik":"0001405104","reported_name":"Norden Gregory","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2026-06-12T21:23:45.000Z","date":"2026-06-10","kind":"grant","planned":false,"acquired":true,"shares":1371,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Mr. Norden was awarded 1,371 restricted stock units. Each restricted stock unit represents a contingent right to receive one share of the Issuer's common stock. The restricted stock units vest in a single annual installment on the earlier of (i) June 10, 2027 or (ii) the date of the Issuer's 2027 annual meeting of stockholders. The restricted stock units may be settled only by delivering shares of the Issuer's common stock, and thus, the grant is being reported in Table 1 as allowed per SEC guidance."}],"balance_after":1559,"source":{"system":"sec-edgar","filing":"0001689548-26-000057","document":"wk-form4_1781299421.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1689548/000168954826000057/wk-form4_1781299421.xml","form_type":"4"}},{"id":772113,"issuer":{"id":3538,"kind":"organization","name":"Praxis Precision Medicines, Inc."},"owners":[{"id":45990,"kind":"person","name":"Mastrocola Lauren","position":1,"cik":"0001827639","reported_name":"Mastrocola Lauren","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Principal Accounting Officer"}}],"security":"Common Stock","published_at":"2026-05-20T01:45:41.000Z","date":"2026-05-14","kind":"grant","planned":false,"acquired":true,"shares":127,"price":167.943,"value":21328.761,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"These shares were acquired under the Praxis Precision Medicines, Inc. Employee Stock Purchase Plan in transactions that were exempt under both Rule 16b-3(d) and Rule 16b-3(c)."}],"balance_after":13572.656,"source":{"system":"sec-edgar","filing":"0001827639-26-000007","document":"wk-form4_1779241539.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1689548/000182763926000007/wk-form4_1779241539.xml","form_type":"4"}},{"id":772111,"issuer":{"id":3538,"kind":"organization","name":"Praxis Precision Medicines, Inc."},"owners":[{"id":45988,"kind":"person","name":"Nemiroff Alex","position":1,"cik":"0001827760","reported_name":"Nemiroff Alex","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"General Counsel and Secretary"}}],"security":"Common Stock","published_at":"2026-05-20T01:45:18.000Z","date":"2026-05-14","kind":"grant","planned":false,"acquired":true,"shares":78,"price":167.943,"value":13099.554,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"These shares were acquired under the Praxis Precision Medicines, Inc. Employee Stock Purchase Plan in transactions that were exempt under both Rule 16b-3(d) and Rule 16b-3(c)."}],"balance_after":26010.667,"source":{"system":"sec-edgar","filing":"0001827760-26-000007","document":"wk-form4_1779241516.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1689548/000182776026000007/wk-form4_1779241516.xml","form_type":"4"}},{"id":772338,"issuer":{"id":3538,"kind":"organization","name":"Praxis Precision Medicines, Inc."},"owners":[{"id":46016,"kind":"person","name":"Kelly Timothy Edwin","position":1,"cik":"0001863297","reported_name":"Kelly Timothy Edwin","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Common Stock","published_at":"2026-05-20T01:44:39.000Z","date":"2026-05-14","kind":"grant","planned":false,"acquired":true,"shares":121,"price":167.943,"value":20321.103,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"These shares were acquired under the Praxis Precision Medicines, Inc. Employee Stock Purchase Plan in transactions that were exempt under both Rule 16b-3(d) and Rule 16b-3(c)."}],"balance_after":31167,"source":{"system":"sec-edgar","filing":"0001689548-26-000050","document":"wk-form4_1779241477.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1863297/000168954826000050/wk-form4_1779241477.xml","form_type":"4"}},{"id":772169,"issuer":{"id":3538,"kind":"organization","name":"Praxis Precision Medicines, Inc."},"owners":[{"id":45998,"kind":"person","name":"Sniecinski Megan","position":1,"cik":"0001781480","reported_name":"Sniecinski Megan","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Operating Officer"}}],"security":"Common Stock","published_at":"2026-05-20T01:43:07.000Z","date":"2026-05-14","kind":"grant","planned":false,"acquired":true,"shares":89,"price":167.943,"value":14946.927,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"These shares were acquired under the Praxis Precision Medicines, Inc. Employee Stock Purchase Plan in transactions that were exempt under both Rule 16b-3(d) and Rule 16b-3(c)."}],"balance_after":28664,"source":{"system":"sec-edgar","filing":"0001781480-26-000008","document":"wk-form4_1779241385.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1781480/000178148026000008/wk-form4_1779241385.xml","form_type":"4"}},{"id":772126,"issuer":{"id":3538,"kind":"organization","name":"Praxis Precision Medicines, Inc."},"owners":[{"id":31447,"kind":"person","name":"Souza Marcio","position":1,"cik":"0001707657","reported_name":"Souza Marcio","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Common Stock","published_at":"2026-05-20T01:42:46.000Z","date":"2026-05-14","kind":"grant","planned":false,"acquired":true,"shares":126,"price":167.943,"value":21160.818,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"These shares were acquired under the Praxis Precision Medicines, Inc. Employee Stock Purchase Plan in transactions that were exempt under both Rule 16b-3(d) and Rule 16b-3(c)."}],"balance_after":77016,"source":{"system":"sec-edgar","filing":"0001707657-26-000005","document":"wk-form4_1779241363.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1707657/000170765726000005/wk-form4_1779241363.xml","form_type":"4"}},{"id":911999,"issuer":{"id":3538,"kind":"organization","name":"Praxis Precision Medicines, Inc."},"owners":[{"id":15072,"kind":"person","name":"Arbuckle Stuart A","position":1,"cik":"0001557290","reported_name":"Arbuckle Stuart A","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2026-02-10T21:59:33.000Z","date":"2026-02-06","kind":"grant","planned":false,"acquired":true,"shares":224,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"The shares subject to this option shall vest in equal monthly installments occurring on the 26th day of each month, with the first such installment occurring on February 26, 2026 and the final such installment occurring on the earlier of (i) June 26, 2026 or (ii) the date of the Issuer's 2026 annual meeting of stockholders."}],"balance_after":224,"derivative":{"exercise_price":319.57,"expiration_date":"2036-02-06","underlying":"Common Stock","underlying_shares":224},"source":{"system":"sec-edgar","filing":"0001689548-26-000018","document":"wk-form4_1770760770.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1689548/000168954826000018/wk-form4_1770760770.xml","form_type":"4"}},{"id":911998,"issuer":{"id":3538,"kind":"organization","name":"Praxis Precision Medicines, Inc."},"owners":[{"id":15072,"kind":"person","name":"Arbuckle Stuart A","position":1,"cik":"0001557290","reported_name":"Arbuckle Stuart A","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2026-02-10T21:59:33.000Z","date":"2026-02-06","kind":"grant","planned":false,"acquired":true,"shares":478,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F2","text":"Mr. Arbuckle was awarded 478 restricted stock units. Each restricted stock unit represents a contingent right to receive one share of the Issuer's common stock. The restricted stock units vest in a single annual installment on the earlier of (i) June 26, 2026 or (ii) the date of the Issuer's 2026 annual meeting of stockholders. The restricted stock units may be settled only by delivering shares of the Issuer's common stock, and thus, the grant is being reported in Table 1 as allowed per SEC guidance."}],"balance_after":1166,"source":{"system":"sec-edgar","filing":"0001689548-26-000018","document":"wk-form4_1770760770.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1689548/000168954826000018/wk-form4_1770760770.xml","form_type":"4"}},{"id":911997,"issuer":{"id":3538,"kind":"organization","name":"Praxis Precision Medicines, Inc."},"owners":[{"id":15072,"kind":"person","name":"Arbuckle Stuart A","position":1,"cik":"0001557290","reported_name":"Arbuckle Stuart A","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2026-02-10T21:59:33.000Z","date":"2026-02-06","kind":"grant","planned":false,"acquired":true,"shares":688,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Mr. Arbuckle was awarded 688 restricted stock units. Each restricted stock unit represents a contingent right to receive one share of the Issuer's common stock. The restricted stock units vest in two equal annual installments occurring on the first two anniversaries of January 8, 2026. The restricted stock units may be settled only by delivering shares of the Issuer's common stock, and thus, the grant is being reported in Table 1 as allowed per SEC guidance."}],"balance_after":688,"source":{"system":"sec-edgar","filing":"0001689548-26-000018","document":"wk-form4_1770760770.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1689548/000168954826000018/wk-form4_1770760770.xml","form_type":"4"}},{"id":912499,"issuer":{"id":3538,"kind":"organization","name":"Praxis Precision Medicines, Inc."},"owners":[{"id":16924,"kind":"person","name":"KINDLER JEFFREY B","position":1,"cik":"0001174454","reported_name":"KINDLER JEFFREY B","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2026-02-10T21:57:40.000Z","date":"2026-02-06","kind":"grant","planned":false,"acquired":true,"shares":224,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"The shares subject to this option shall vest in equal monthly installments occurring on the 26th day of each month, with the first such installment occurring on February 26, 2026 and the final such installment occurring on the earlier of (i) June 26, 2026 or (ii) the date of the Issuer's 2026 annual meeting of stockholders."}],"balance_after":224,"derivative":{"exercise_price":319.57,"expiration_date":"2036-02-06","underlying":"Common Stock","underlying_shares":224},"source":{"system":"sec-edgar","filing":"0001689548-26-000017","document":"wk-form4_1770760657.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1174454/000168954826000017/wk-form4_1770760657.xml","form_type":"4"}},{"id":912498,"issuer":{"id":3538,"kind":"organization","name":"Praxis Precision Medicines, Inc."},"owners":[{"id":16924,"kind":"person","name":"KINDLER JEFFREY B","position":1,"cik":"0001174454","reported_name":"KINDLER JEFFREY B","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2026-02-10T21:57:40.000Z","date":"2026-02-06","kind":"grant","planned":false,"acquired":true,"shares":478,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F2","text":"Mr. Kindler was awarded 478 restricted stock units. Each restricted stock unit represents a contingent right to receive one share of the Issuer's common stock. The restricted stock units vest in a single annual installment on the earlier of (i) June 26, 2026 or (ii) the date of the Issuer's 2026 annual meeting of stockholders. The restricted stock units may be settled only by delivering shares of the Issuer's common stock, and thus, the grant is being reported in Table 1 as allowed per SEC guidance."}],"balance_after":1166,"source":{"system":"sec-edgar","filing":"0001689548-26-000017","document":"wk-form4_1770760657.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1174454/000168954826000017/wk-form4_1770760657.xml","form_type":"4"}},{"id":912497,"issuer":{"id":3538,"kind":"organization","name":"Praxis Precision Medicines, Inc."},"owners":[{"id":16924,"kind":"person","name":"KINDLER JEFFREY B","position":1,"cik":"0001174454","reported_name":"KINDLER JEFFREY B","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2026-02-10T21:57:40.000Z","date":"2026-02-06","kind":"grant","planned":false,"acquired":true,"shares":688,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Mr. Kindler was awarded 688 restricted stock units. Each restricted stock unit represents a contingent right to receive one share of the Issuer's common stock. The restricted stock units vest in two equal annual installments occurring on the first two anniversaries of January 8, 2026. The restricted stock units may be settled only by delivering shares of the Issuer's common stock, and thus, the grant is being reported in Table 1 as allowed per SEC guidance."}],"balance_after":688,"source":{"system":"sec-edgar","filing":"0001689548-26-000017","document":"wk-form4_1770760657.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1174454/000168954826000017/wk-form4_1770760657.xml","form_type":"4"}},{"id":940072,"issuer":{"id":3538,"kind":"organization","name":"Praxis Precision Medicines, Inc."},"owners":[{"id":45990,"kind":"person","name":"Mastrocola Lauren","position":1,"cik":"0001827639","reported_name":"Mastrocola Lauren","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Principal Accounting Officer"}}],"security":"Common Stock","published_at":"2026-01-14T01:20:33.000Z","date":"2026-01-12","kind":"tax_withholding","planned":false,"acquired":false,"shares":344,"price":275.74,"value":94854.56,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Shares withheld by the Issuer to satisfy the tax withholding obligations in connection with the vesting of certain previously reported restricted stock units."}],"balance_after":13445.656,"source":{"system":"sec-edgar","filing":"0001827639-26-000005","document":"wk-form4_1768353630.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1689548/000182763926000005/wk-form4_1768353630.xml","form_type":"4"}},{"id":940101,"issuer":{"id":3538,"kind":"organization","name":"Praxis Precision Medicines, Inc."},"owners":[{"id":45998,"kind":"person","name":"Sniecinski Megan","position":1,"cik":"0001781480","reported_name":"Sniecinski Megan","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Operating Officer"}}],"security":"Common Stock","published_at":"2026-01-14T01:19:50.000Z","date":"2026-01-12","kind":"tax_withholding","planned":false,"acquired":false,"shares":885,"price":275.74,"value":244029.9,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Shares withheld by the Issuer to satisfy the tax withholding obligations in connection with the vesting of certain previously reported restricted stock units."}],"balance_after":28530,"source":{"system":"sec-edgar","filing":"0001781480-26-000006","document":"wk-form4_1768353587.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1781480/000178148026000006/wk-form4_1768353587.xml","form_type":"4"}},{"id":940063,"issuer":{"id":3538,"kind":"organization","name":"Praxis Precision Medicines, Inc."},"owners":[{"id":45988,"kind":"person","name":"Nemiroff Alex","position":1,"cik":"0001827760","reported_name":"Nemiroff Alex","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"General Counsel and Secretary"}}],"security":"Common Stock","published_at":"2026-01-14T01:19:19.000Z","date":"2026-01-12","kind":"tax_withholding","planned":false,"acquired":false,"shares":768,"price":275.74,"value":211768.32,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Shares withheld by the Issuer to satisfy the tax withholding obligations in connection with the vesting of certain previously reported restricted stock units."}],"balance_after":25932.667,"source":{"system":"sec-edgar","filing":"0001827760-26-000005","document":"wk-form4_1768353556.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1689548/000182776026000005/wk-form4_1768353556.xml","form_type":"4"}},{"id":940141,"issuer":{"id":3538,"kind":"organization","name":"Praxis Precision Medicines, Inc."},"owners":[{"id":46016,"kind":"person","name":"Kelly Timothy Edwin","position":1,"cik":"0001863297","reported_name":"Kelly Timothy Edwin","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Common Stock","published_at":"2026-01-14T01:18:33.000Z","date":"2026-01-12","kind":"tax_withholding","planned":false,"acquired":false,"shares":943,"price":275.74,"value":260022.82,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Shares withheld by the Issuer to satisfy the tax withholding obligations in connection with the vesting of certain previously reported restricted stock units."}],"balance_after":31046,"source":{"system":"sec-edgar","filing":"0001863297-26-000005","document":"wk-form4_1768353511.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1863297/000186329726000005/wk-form4_1768353511.xml","form_type":"4"}},{"id":941020,"issuer":{"id":3538,"kind":"organization","name":"Praxis Precision Medicines, Inc."},"owners":[{"id":45990,"kind":"person","name":"Mastrocola Lauren","position":1,"cik":"0001827639","reported_name":"Mastrocola Lauren","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Principal Accounting Officer"}}],"security":"Stock Option (Right to Buy)","published_at":"2026-01-12T22:51:02.000Z","date":"2026-01-08","kind":"grant","planned":false,"acquired":true,"shares":7500,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"The shares underlying this stock option vest over a four-year period, with 25% vesting on January 8, 2027 and the remaining 75% vesting in 36 equal monthly installments thereafter, subject to the reporting person's continued service through each vesting date."}],"balance_after":7500,"derivative":{"exercise_price":294.38,"expiration_date":"2036-01-08","underlying":"Common Stock","underlying_shares":7500},"source":{"system":"sec-edgar","filing":"0001689548-26-000014","document":"wk-form4_1768258260.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1689548/000168954826000014/wk-form4_1768258260.xml","form_type":"4"}},{"id":941019,"issuer":{"id":3538,"kind":"organization","name":"Praxis Precision Medicines, Inc."},"owners":[{"id":45990,"kind":"person","name":"Mastrocola Lauren","position":1,"cik":"0001827639","reported_name":"Mastrocola Lauren","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Principal Accounting Officer"}}],"security":"Common Stock","published_at":"2026-01-12T22:51:02.000Z","date":"2026-01-10","kind":"tax_withholding","planned":false,"acquired":false,"shares":367,"price":288.45,"value":105861.15,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F2","text":"Shares withheld by the Issuer to satisfy the tax withholding obligations in connection with the vesting of certain previously reported restricted stock units."}],"balance_after":13789.656,"source":{"system":"sec-edgar","filing":"0001689548-26-000014","document":"wk-form4_1768258260.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1689548/000168954826000014/wk-form4_1768258260.xml","form_type":"4"}},{"id":941018,"issuer":{"id":3538,"kind":"organization","name":"Praxis Precision Medicines, Inc."},"owners":[{"id":45990,"kind":"person","name":"Mastrocola Lauren","position":1,"cik":"0001827639","reported_name":"Mastrocola Lauren","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Principal Accounting Officer"}}],"security":"Common Stock","published_at":"2026-01-12T22:51:02.000Z","date":"2026-01-08","kind":"grant","planned":false,"acquired":true,"shares":3750,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Ms. Mastrocola was awarded 3,750 restricted stock units. Each restricted stock unit represents a contingent right to receive one share of the Issuer's Common Stock. The restricted stock units vest in equal annual installments over a four-year period beginning on the one-year anniversary of the vesting commencement date of January 8, 2026. The restricted stock units may be settled only by delivering shares of the Issuer's Common Stock, and thus, the grant is being reported in Table 1 as allowed per SEC guidance."}],"balance_after":14156.656,"source":{"system":"sec-edgar","filing":"0001689548-26-000014","document":"wk-form4_1768258260.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1689548/000168954826000014/wk-form4_1768258260.xml","form_type":"4"}},{"id":941082,"issuer":{"id":3538,"kind":"organization","name":"Praxis Precision Medicines, Inc."},"owners":[{"id":45998,"kind":"person","name":"Sniecinski Megan","position":1,"cik":"0001781480","reported_name":"Sniecinski Megan","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Operating Officer"}}],"security":"Stock Option (Right to Buy)","published_at":"2026-01-12T22:50:29.000Z","date":"2026-01-08","kind":"grant","planned":false,"acquired":true,"shares":7700,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"The shares underlying this stock option vest over a four-year period, with 25% vesting on January 8, 2027 and the remaining 75% vesting in 36 equal monthly installments thereafter, subject to the reporting person's continued service through each vesting date."}],"balance_after":7700,"derivative":{"exercise_price":294.38,"expiration_date":"2036-01-08","underlying":"Common Stock","underlying_shares":7700},"source":{"system":"sec-edgar","filing":"0001689548-26-000013","document":"wk-form4_1768258226.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1781480/000168954826000013/wk-form4_1768258226.xml","form_type":"4"}},{"id":941081,"issuer":{"id":3538,"kind":"organization","name":"Praxis Precision Medicines, Inc."},"owners":[{"id":45998,"kind":"person","name":"Sniecinski Megan","position":1,"cik":"0001781480","reported_name":"Sniecinski Megan","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Operating Officer"}}],"security":"Common Stock","published_at":"2026-01-12T22:50:29.000Z","date":"2026-01-10","kind":"tax_withholding","planned":false,"acquired":false,"shares":1087,"price":288.45,"value":313545.15,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F2","text":"Shares withheld by the Issuer to satisfy the tax withholding obligations in connection with the vesting of certain previously reported restricted stock units."}],"balance_after":29415,"source":{"system":"sec-edgar","filing":"0001689548-26-000013","document":"wk-form4_1768258226.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1781480/000168954826000013/wk-form4_1768258226.xml","form_type":"4"}},{"id":941080,"issuer":{"id":3538,"kind":"organization","name":"Praxis Precision Medicines, Inc."},"owners":[{"id":45998,"kind":"person","name":"Sniecinski Megan","position":1,"cik":"0001781480","reported_name":"Sniecinski Megan","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Operating Officer"}}],"security":"Common Stock","published_at":"2026-01-12T22:50:29.000Z","date":"2026-01-08","kind":"grant","planned":false,"acquired":true,"shares":9625,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Ms. Sniecinski was awarded 9,625 restricted stock units. Each restricted stock unit represents a contingent right to receive one share of the Issuer's Common Stock. The restricted stock units vest in equal annual installments over a four-year period beginning on the one-year anniversary of the vesting commencement date of January 8, 2026. The restricted stock units may be settled only by delivering shares of the Issuer's Common Stock, and thus, the grant is being reported in Table 1 as allowed per SEC guidance."}],"balance_after":30502,"source":{"system":"sec-edgar","filing":"0001689548-26-000013","document":"wk-form4_1768258226.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1781480/000168954826000013/wk-form4_1768258226.xml","form_type":"4"}},{"id":941017,"issuer":{"id":3538,"kind":"organization","name":"Praxis Precision Medicines, Inc."},"owners":[{"id":45988,"kind":"person","name":"Nemiroff Alex","position":1,"cik":"0001827760","reported_name":"Nemiroff Alex","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"General Counsel and Secretary"}}],"security":"Stock Option (Right to Buy)","published_at":"2026-01-12T22:49:56.000Z","date":"2026-01-08","kind":"grant","planned":false,"acquired":true,"shares":5500,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"The shares underlying this stock option vest over a four-year period, with 25% vesting on January 8, 2027 and the remaining 75% vesting in 36 equal monthly installments thereafter, subject to the reporting person's continued service through each vesting date."}],"balance_after":5500,"derivative":{"exercise_price":294.38,"expiration_date":"2036-01-08","underlying":"Common Stock","underlying_shares":5500},"source":{"system":"sec-edgar","filing":"0001689548-26-000012","document":"wk-form4_1768258193.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1689548/000168954826000012/wk-form4_1768258193.xml","form_type":"4"}},{"id":941016,"issuer":{"id":3538,"kind":"organization","name":"Praxis Precision Medicines, Inc."},"owners":[{"id":45988,"kind":"person","name":"Nemiroff Alex","position":1,"cik":"0001827760","reported_name":"Nemiroff Alex","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"General Counsel and Secretary"}}],"security":"Common Stock","published_at":"2026-01-12T22:49:56.000Z","date":"2026-01-10","kind":"tax_withholding","planned":false,"acquired":false,"shares":917,"price":288.45,"value":264508.65,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F2","text":"Shares withheld by the Issuer to satisfy the tax withholding obligations in connection with the vesting of certain previously reported restricted stock units."}],"balance_after":26700.667,"source":{"system":"sec-edgar","filing":"0001689548-26-000012","document":"wk-form4_1768258193.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1689548/000168954826000012/wk-form4_1768258193.xml","form_type":"4"}},{"id":941015,"issuer":{"id":3538,"kind":"organization","name":"Praxis Precision Medicines, Inc."},"owners":[{"id":45988,"kind":"person","name":"Nemiroff Alex","position":1,"cik":"0001827760","reported_name":"Nemiroff Alex","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"General Counsel and Secretary"}}],"security":"Common Stock","published_at":"2026-01-12T22:49:56.000Z","date":"2026-01-08","kind":"grant","planned":false,"acquired":true,"shares":6875,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Mr. Nemiroff was awarded 6,875 restricted stock units. Each restricted stock unit represents a contingent right to receive one share of the Issuer's Common Stock. The restricted stock units vest in equal annual installments over a four-year period beginning on the one-year anniversary of the vesting commencement date of January 8, 2026. The restricted stock units may be settled only by delivering shares of the Issuer's Common Stock, and thus, the grant is being reported in Table 1 as allowed per SEC guidance."}],"balance_after":27617.667,"source":{"system":"sec-edgar","filing":"0001689548-26-000012","document":"wk-form4_1768258193.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1689548/000168954826000012/wk-form4_1768258193.xml","form_type":"4"}},{"id":941123,"issuer":{"id":3538,"kind":"organization","name":"Praxis Precision Medicines, Inc."},"owners":[{"id":46016,"kind":"person","name":"Kelly Timothy Edwin","position":1,"cik":"0001863297","reported_name":"Kelly Timothy Edwin","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Stock Option (Right to Buy)","published_at":"2026-01-12T22:49:02.000Z","date":"2026-01-08","kind":"grant","planned":false,"acquired":true,"shares":7040,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"The shares underlying this stock option vest over a four-year period, with 25% vesting on January 8, 2027 and the remaining 75% vesting in 36 equal monthly installments thereafter, subject to the reporting person's continued service through each vesting date."}],"balance_after":7040,"derivative":{"exercise_price":294.38,"expiration_date":"2036-01-08","underlying":"Common Stock","underlying_shares":7040},"source":{"system":"sec-edgar","filing":"0001689548-26-000011","document":"wk-form4_1768258139.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1863297/000168954826000011/wk-form4_1768258139.xml","form_type":"4"}},{"id":941122,"issuer":{"id":3538,"kind":"organization","name":"Praxis Precision Medicines, Inc."},"owners":[{"id":46016,"kind":"person","name":"Kelly Timothy Edwin","position":1,"cik":"0001863297","reported_name":"Kelly Timothy Edwin","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Common Stock","published_at":"2026-01-12T22:49:02.000Z","date":"2026-01-10","kind":"tax_withholding","planned":false,"acquired":false,"shares":1335,"price":288.45,"value":385080.75,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F2","text":"Shares withheld by the Issuer to satisfy the tax withholding obligations in connection with the vesting of certain previously reported restricted stock units."}],"balance_after":31989,"source":{"system":"sec-edgar","filing":"0001689548-26-000011","document":"wk-form4_1768258139.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1863297/000168954826000011/wk-form4_1768258139.xml","form_type":"4"}},{"id":941121,"issuer":{"id":3538,"kind":"organization","name":"Praxis Precision Medicines, Inc."},"owners":[{"id":46016,"kind":"person","name":"Kelly Timothy Edwin","position":1,"cik":"0001863297","reported_name":"Kelly Timothy Edwin","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Common Stock","published_at":"2026-01-12T22:49:02.000Z","date":"2026-01-08","kind":"grant","planned":false,"acquired":true,"shares":8800,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Mr. Kelly was awarded 8,800 restricted stock units. Each restricted stock unit represents a contingent right to receive one share of the Issuer's Common Stock. The restricted stock units vest in equal annual installments over a four-year period beginning on the one-year anniversary of the vesting commencement date of January 8, 2026. The restricted stock units may be settled only by delivering shares of the Issuer's Common Stock, and thus, the grant is being reported in Table 1 as allowed per SEC guidance."}],"balance_after":33324,"source":{"system":"sec-edgar","filing":"0001689548-26-000011","document":"wk-form4_1768258139.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1863297/000168954826000011/wk-form4_1768258139.xml","form_type":"4"}},{"id":941032,"issuer":{"id":3538,"kind":"organization","name":"Praxis Precision Medicines, Inc."},"owners":[{"id":31447,"kind":"person","name":"Souza Marcio","position":1,"cik":"0001707657","reported_name":"Souza Marcio","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Stock Option (Right to Buy)","published_at":"2026-01-12T22:48:23.000Z","date":"2026-01-08","kind":"grant","planned":false,"acquired":true,"shares":22110,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"The shares underlying this stock option vest over a four-year period, with 25% vesting on January 8, 2027 and the remaining 75% vesting in 36 equal monthly installments thereafter, subject to the reporting person's continued service through each vesting date."}],"balance_after":22110,"derivative":{"exercise_price":294.38,"expiration_date":"2036-01-08","underlying":"Common Stock","underlying_shares":22110},"source":{"system":"sec-edgar","filing":"0001689548-26-000010","document":"wk-form4_1768258100.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1707657/000168954826000010/wk-form4_1768258100.xml","form_type":"4"}},{"id":941031,"issuer":{"id":3538,"kind":"organization","name":"Praxis Precision Medicines, Inc."},"owners":[{"id":31447,"kind":"person","name":"Souza Marcio","position":1,"cik":"0001707657","reported_name":"Souza Marcio","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Common Stock","published_at":"2026-01-12T22:48:23.000Z","date":"2026-01-10","kind":"tax_withholding","planned":false,"acquired":false,"shares":4252,"price":288.45,"value":1226489.4,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F2","text":"Shares withheld by the Issuer to satisfy the tax withholding obligations in connection with the vesting of certain previously reported restricted stock units."}],"balance_after":76890,"source":{"system":"sec-edgar","filing":"0001689548-26-000010","document":"wk-form4_1768258100.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1707657/000168954826000010/wk-form4_1768258100.xml","form_type":"4"}},{"id":941030,"issuer":{"id":3538,"kind":"organization","name":"Praxis Precision Medicines, Inc."},"owners":[{"id":31447,"kind":"person","name":"Souza Marcio","position":1,"cik":"0001707657","reported_name":"Souza Marcio","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Common Stock","published_at":"2026-01-12T22:48:23.000Z","date":"2026-01-08","kind":"grant","planned":false,"acquired":true,"shares":27640,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Mr. Souza was awarded 27,640 restricted stock units. Each restricted stock unit represents a contingent right to receive one share of the Issuer's Common Stock. The restricted stock units vest in\nequal annual installments over a four-year period beginning on the one-year anniversary of the vesting commencement date of January 8, 2026. The restricted stock units may be settled only by\ndelivering shares of the Issuer's Common Stock, and thus, the grant is being reported in Table 1 as allowed per SEC guidance."}],"balance_after":81142,"source":{"system":"sec-edgar","filing":"0001689548-26-000010","document":"wk-form4_1768258100.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1707657/000168954826000010/wk-form4_1768258100.xml","form_type":"4"}},{"id":942138,"issuer":{"id":3538,"kind":"organization","name":"Praxis Precision Medicines, Inc."},"owners":[{"id":45990,"kind":"person","name":"Mastrocola Lauren","position":1,"cik":"0001827639","reported_name":"Mastrocola Lauren","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Principal Accounting Officer"}}],"security":"Common Stock","published_at":"2026-01-09T21:47:53.000Z","date":"2026-01-07","kind":"tax_withholding","planned":false,"acquired":false,"shares":35,"price":292.63,"value":10242.05,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Shares withheld by the Issuer to satisfy the tax withholding obligations in connection with the vesting of certain previously reported restricted stock units."}],"balance_after":10406.656,"source":{"system":"sec-edgar","filing":"0001827639-26-000002","document":"wk-form4_1767995270.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1689548/000182763926000002/wk-form4_1767995270.xml","form_type":"4"}},{"id":942137,"issuer":{"id":3538,"kind":"organization","name":"Praxis Precision Medicines, Inc."},"owners":[{"id":45988,"kind":"person","name":"Nemiroff Alex","position":1,"cik":"0001827760","reported_name":"Nemiroff Alex","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"General Counsel and Secretary"}}],"security":"Common Stock","published_at":"2026-01-09T21:47:25.000Z","date":"2026-01-07","kind":"tax_withholding","planned":false,"acquired":false,"shares":89,"price":292.63,"value":26044.07,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Shares withheld by the Issuer to satisfy the tax withholding obligations in connection with the vesting of certain previously reported restricted stock units."}],"balance_after":20742.667,"source":{"system":"sec-edgar","filing":"0001827760-26-000002","document":"wk-form4_1767995242.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1689548/000182776026000002/wk-form4_1767995242.xml","form_type":"4"}},{"id":942271,"issuer":{"id":3538,"kind":"organization","name":"Praxis Precision Medicines, Inc."},"owners":[{"id":46016,"kind":"person","name":"Kelly Timothy Edwin","position":1,"cik":"0001863297","reported_name":"Kelly Timothy Edwin","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Common Stock","published_at":"2026-01-09T21:47:02.000Z","date":"2026-01-07","kind":"tax_withholding","planned":false,"acquired":false,"shares":139,"price":292.63,"value":40675.57,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Shares withheld by the Issuer to satisfy the tax withholding obligations in connection with the vesting of certain previously reported restricted stock units."}],"balance_after":24524,"source":{"system":"sec-edgar","filing":"0001863297-26-000002","document":"wk-form4_1767995220.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1863297/000186329726000002/wk-form4_1767995220.xml","form_type":"4"}},{"id":942143,"issuer":{"id":3538,"kind":"organization","name":"Praxis Precision Medicines, Inc."},"owners":[{"id":31447,"kind":"person","name":"Souza Marcio","position":1,"cik":"0001707657","reported_name":"Souza Marcio","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Common Stock","published_at":"2026-01-09T21:46:36.000Z","date":"2026-01-07","kind":"tax_withholding","planned":false,"acquired":false,"shares":405,"price":292.63,"value":118515.15,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Shares withheld by the Issuer to satisfy the tax withholding obligations in connection with the vesting of certain previously reported restricted stock units."}],"balance_after":53502,"source":{"system":"sec-edgar","filing":"0001707657-26-000002","document":"wk-form4_1767995193.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1707657/000170765726000002/wk-form4_1767995193.xml","form_type":"4"}},{"id":956559,"issuer":{"id":3538,"kind":"organization","name":"Praxis Precision Medicines, Inc."},"owners":[{"id":31447,"kind":"person","name":"Souza Marcio","position":1,"cik":"0001707657","reported_name":"Souza Marcio","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Common Stock","published_at":"2026-01-01T00:17:43.000Z","date":"2025-12-30","kind":"gift","planned":false,"acquired":false,"shares":400,"price":0,"value":0.0,"ownership":{"direct":false,"nature":"Held by spouse"},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Shares were transferred as a gift to a charitable fund."}],"balance_after":2600,"source":{"system":"sec-edgar","filing":"0001707657-25-000004","document":"wk-form4_1767226660.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1707657/000170765725000004/wk-form4_1767226660.xml","form_type":"4"}},{"id":991464,"issuer":{"id":3538,"kind":"organization","name":"Praxis Precision Medicines, Inc."},"owners":[{"id":46016,"kind":"person","name":"Kelly Timothy Edwin","position":1,"cik":"0001863297","reported_name":"Kelly Timothy Edwin","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Common Stock","published_at":"2025-11-22T02:42:37.000Z","date":"2025-11-14","kind":"grant","planned":false,"acquired":true,"shares":384,"price":31.62,"value":12142.08,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"These shares were acquired under the Praxis Precision Medicines, Inc. Employee Stock Purchase Plan in transactions that were exempt under both Rule 16b-3(d) and Rule 16b-3(c)."}],"balance_after":24663,"source":{"system":"sec-edgar","filing":"0001104659-25-115100","document":"tm2531977-3_4seq1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1863297/000110465925115100/tm2531977-3_4seq1.xml","form_type":"4"}},{"id":991396,"issuer":{"id":3538,"kind":"organization","name":"Praxis Precision Medicines, Inc."},"owners":[{"id":45988,"kind":"person","name":"Nemiroff Alex","position":1,"cik":"0001827760","reported_name":"Nemiroff Alex","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"General Counsel and Secretary"}}],"security":"Stock Option (Right to Buy)","published_at":"2025-11-22T02:41:39.000Z","date":"2025-11-20","kind":"exercise","planned":false,"acquired":false,"shares":9100,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F7","text":"The shares underlying this stock option vested as to 7/48ths on July 29, 2024 and the remaining shares vest in substantially equal monthly installments over the following 41 months, subject to the Reporting Person's continued service through each vesting date."}],"balance_after":19717,"derivative":{"exercise_price":56.94,"expiration_date":"2034-07-29","underlying":"Common Stock","underlying_shares":9100},"source":{"system":"sec-edgar","filing":"0001104659-25-115099","document":"tm2531977-2_4seq1.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":14,"url":"https://www.sec.gov/Archives/edgar/data/1689548/000110465925115099/tm2531977-2_4seq1.xml","form_type":"4"}},{"id":991395,"issuer":{"id":3538,"kind":"organization","name":"Praxis Precision Medicines, Inc."},"owners":[{"id":45988,"kind":"person","name":"Nemiroff Alex","position":1,"cik":"0001827760","reported_name":"Nemiroff Alex","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"General Counsel and Secretary"}}],"security":"Stock Option (Right to Buy)","published_at":"2025-11-22T02:41:39.000Z","date":"2025-11-20","kind":"exercise","planned":false,"acquired":false,"shares":5652,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F6","text":"The shares underlying this stock option vested as to 25% on January 12, 2024 and the remaining shares vest in substantially equal monthly installments over the following 36 months, subject to the Reporting Person's continued service through each vesting date."}],"balance_after":2347,"derivative":{"exercise_price":44.4,"expiration_date":"2033-01-12","underlying":"Common Stock","underlying_shares":5652},"source":{"system":"sec-edgar","filing":"0001104659-25-115099","document":"tm2531977-2_4seq1.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":13,"url":"https://www.sec.gov/Archives/edgar/data/1689548/000110465925115099/tm2531977-2_4seq1.xml","form_type":"4"}},{"id":991394,"issuer":{"id":3538,"kind":"organization","name":"Praxis Precision Medicines, Inc."},"owners":[{"id":45988,"kind":"person","name":"Nemiroff Alex","position":1,"cik":"0001827760","reported_name":"Nemiroff Alex","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"General Counsel and Secretary"}}],"security":"Stock Option (Right to Buy)","published_at":"2025-11-22T02:41:39.000Z","date":"2025-11-20","kind":"exercise","planned":false,"acquired":false,"shares":2434,"price":0,"value":0.0,"ownership":{"direct":true},"balance_after":0,"derivative":{"exercise_price":44.4,"exercise_date":"2023-01-12","expiration_date":"2033-01-12","underlying":"Common Stock","underlying_shares":2434},"source":{"system":"sec-edgar","filing":"0001104659-25-115099","document":"tm2531977-2_4seq1.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":12,"url":"https://www.sec.gov/Archives/edgar/data/1689548/000110465925115099/tm2531977-2_4seq1.xml","form_type":"4"}},{"id":991393,"issuer":{"id":3538,"kind":"organization","name":"Praxis Precision Medicines, Inc."},"owners":[{"id":45988,"kind":"person","name":"Nemiroff Alex","position":1,"cik":"0001827760","reported_name":"Nemiroff Alex","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"General Counsel and Secretary"}}],"security":"Stock Option (Right to Buy)","published_at":"2025-11-22T02:41:39.000Z","date":"2025-11-20","kind":"exercise","planned":false,"acquired":false,"shares":6230,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F5","text":"This option was fully vested as of September 9, 2024."}],"balance_after":0,"derivative":{"exercise_price":133.65,"expiration_date":"2030-09-13","underlying":"Common Stock","underlying_shares":6230},"source":{"system":"sec-edgar","filing":"0001104659-25-115099","document":"tm2531977-2_4seq1.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":11,"url":"https://www.sec.gov/Archives/edgar/data/1689548/000110465925115099/tm2531977-2_4seq1.xml","form_type":"4"}},{"id":991392,"issuer":{"id":3538,"kind":"organization","name":"Praxis Precision Medicines, Inc."},"owners":[{"id":45988,"kind":"person","name":"Nemiroff Alex","position":1,"cik":"0001827760","reported_name":"Nemiroff Alex","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"General Counsel and Secretary"}}],"security":"Stock Option (Right to Buy)","published_at":"2025-11-22T02:41:39.000Z","date":"2025-11-20","kind":"exercise","planned":false,"acquired":false,"shares":1714,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F4","text":"This option was fully vested as of January 1, 2024."}],"balance_after":0,"derivative":{"exercise_price":83.85,"expiration_date":"2030-06-04","underlying":"Common Stock","underlying_shares":1714},"source":{"system":"sec-edgar","filing":"0001104659-25-115099","document":"tm2531977-2_4seq1.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":10,"url":"https://www.sec.gov/Archives/edgar/data/1689548/000110465925115099/tm2531977-2_4seq1.xml","form_type":"4"}},{"id":991391,"issuer":{"id":3538,"kind":"organization","name":"Praxis Precision Medicines, Inc."},"owners":[{"id":45988,"kind":"person","name":"Nemiroff Alex","position":1,"cik":"0001827760","reported_name":"Nemiroff Alex","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"General Counsel and Secretary"}}],"security":"Common Stock","published_at":"2025-11-22T02:41:39.000Z","date":"2025-11-20","kind":"sale","planned":false,"acquired":false,"shares":9100,"price":194.3,"value":1768130.0,"ownership":{"direct":true},"balance_after":20831.667,"source":{"system":"sec-edgar","filing":"0001104659-25-115099","document":"tm2531977-2_4seq1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":9,"url":"https://www.sec.gov/Archives/edgar/data/1689548/000110465925115099/tm2531977-2_4seq1.xml","form_type":"4"}},{"id":991390,"issuer":{"id":3538,"kind":"organization","name":"Praxis Precision Medicines, Inc."},"owners":[{"id":45988,"kind":"person","name":"Nemiroff Alex","position":1,"cik":"0001827760","reported_name":"Nemiroff Alex","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"General Counsel and Secretary"}}],"security":"Common Stock","published_at":"2025-11-22T02:41:39.000Z","date":"2025-11-20","kind":"sale","planned":false,"acquired":false,"shares":977,"price":193.233,"value":188788.641,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F3","text":"The price reported is a weighted average price. The securities were sold in multiple transactions at per share prices ranging from $193.010 to $193.960. The Reporting Person undertakes to provide upon request from the SEC staff, the Issuer, or any shareholder of the Issuer, full information regarding the number of securities sold at each separate price within the range set forth in this footnote."}],"balance_after":29931.667,"source":{"system":"sec-edgar","filing":"0001104659-25-115099","document":"tm2531977-2_4seq1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":8,"url":"https://www.sec.gov/Archives/edgar/data/1689548/000110465925115099/tm2531977-2_4seq1.xml","form_type":"4"}},{"id":991389,"issuer":{"id":3538,"kind":"organization","name":"Praxis Precision Medicines, Inc."},"owners":[{"id":45988,"kind":"person","name":"Nemiroff Alex","position":1,"cik":"0001827760","reported_name":"Nemiroff Alex","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"General Counsel and Secretary"}}],"security":"Common Stock","published_at":"2025-11-22T02:41:39.000Z","date":"2025-11-20","kind":"sale","planned":false,"acquired":false,"shares":13339,"price":192.533,"value":2568197.687,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The price reported is a weighted average price. The securities were sold in multiple transactions at per share prices ranging from $192.003 to $193.000. The Reporting Person undertakes to provide upon request from the SEC staff, the Issuer, or any shareholder of the Issuer, full information regarding the number of securities sold at each separate price within the range set forth in this footnote."}],"balance_after":30908.667,"source":{"system":"sec-edgar","filing":"0001104659-25-115099","document":"tm2531977-2_4seq1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":7,"url":"https://www.sec.gov/Archives/edgar/data/1689548/000110465925115099/tm2531977-2_4seq1.xml","form_type":"4"}},{"id":991388,"issuer":{"id":3538,"kind":"organization","name":"Praxis Precision Medicines, Inc."},"owners":[{"id":45988,"kind":"person","name":"Nemiroff Alex","position":1,"cik":"0001827760","reported_name":"Nemiroff Alex","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"General Counsel and Secretary"}}],"security":"Common Stock","published_at":"2025-11-22T02:41:39.000Z","date":"2025-11-20","kind":"sale","planned":false,"acquired":false,"shares":1714,"price":190.863,"value":327139.182,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"The price reported is a weighted average price. The securities were sold in multiple transactions at per share prices ranging from $190.720 to $191.540. The Reporting Person undertakes to provide upon request from the SEC staff, the Issuer, or any shareholder of the Issuer, full information regarding the number of securities sold at each separate price within the range set forth in this footnote."}],"balance_after":44247.667,"source":{"system":"sec-edgar","filing":"0001104659-25-115099","document":"tm2531977-2_4seq1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":6,"url":"https://www.sec.gov/Archives/edgar/data/1689548/000110465925115099/tm2531977-2_4seq1.xml","form_type":"4"}},{"id":991387,"issuer":{"id":3538,"kind":"organization","name":"Praxis Precision Medicines, Inc."},"owners":[{"id":45988,"kind":"person","name":"Nemiroff Alex","position":1,"cik":"0001827760","reported_name":"Nemiroff Alex","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"General Counsel and Secretary"}}],"security":"Common Stock","published_at":"2025-11-22T02:41:39.000Z","date":"2025-11-20","kind":"exercise","planned":false,"acquired":true,"shares":9100,"price":56.94,"value":518154.0,"ownership":{"direct":true},"balance_after":45961.667,"source":{"system":"sec-edgar","filing":"0001104659-25-115099","document":"tm2531977-2_4seq1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/1689548/000110465925115099/tm2531977-2_4seq1.xml","form_type":"4"}},{"id":991386,"issuer":{"id":3538,"kind":"organization","name":"Praxis Precision Medicines, Inc."},"owners":[{"id":45988,"kind":"person","name":"Nemiroff Alex","position":1,"cik":"0001827760","reported_name":"Nemiroff Alex","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"General Counsel and Secretary"}}],"security":"Common Stock","published_at":"2025-11-22T02:41:39.000Z","date":"2025-11-20","kind":"exercise","planned":false,"acquired":true,"shares":5652,"price":44.4,"value":250948.8,"ownership":{"direct":true},"balance_after":36861.667,"source":{"system":"sec-edgar","filing":"0001104659-25-115099","document":"tm2531977-2_4seq1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1689548/000110465925115099/tm2531977-2_4seq1.xml","form_type":"4"}},{"id":991385,"issuer":{"id":3538,"kind":"organization","name":"Praxis Precision Medicines, Inc."},"owners":[{"id":45988,"kind":"person","name":"Nemiroff Alex","position":1,"cik":"0001827760","reported_name":"Nemiroff Alex","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"General Counsel and Secretary"}}],"security":"Common Stock","published_at":"2025-11-22T02:41:39.000Z","date":"2025-11-20","kind":"exercise","planned":false,"acquired":true,"shares":2434,"price":44.4,"value":108069.6,"ownership":{"direct":true},"balance_after":31209.667,"source":{"system":"sec-edgar","filing":"0001104659-25-115099","document":"tm2531977-2_4seq1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1689548/000110465925115099/tm2531977-2_4seq1.xml","form_type":"4"}},{"id":991384,"issuer":{"id":3538,"kind":"organization","name":"Praxis Precision Medicines, Inc."},"owners":[{"id":45988,"kind":"person","name":"Nemiroff Alex","position":1,"cik":"0001827760","reported_name":"Nemiroff Alex","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"General Counsel and Secretary"}}],"security":"Common Stock","published_at":"2025-11-22T02:41:39.000Z","date":"2025-11-20","kind":"exercise","planned":false,"acquired":true,"shares":6230,"price":133.65,"value":832639.5,"ownership":{"direct":true},"balance_after":28775.667,"source":{"system":"sec-edgar","filing":"0001104659-25-115099","document":"tm2531977-2_4seq1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1689548/000110465925115099/tm2531977-2_4seq1.xml","form_type":"4"}},{"id":991383,"issuer":{"id":3538,"kind":"organization","name":"Praxis Precision Medicines, Inc."},"owners":[{"id":45988,"kind":"person","name":"Nemiroff Alex","position":1,"cik":"0001827760","reported_name":"Nemiroff Alex","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"General Counsel and Secretary"}}],"security":"Common Stock","published_at":"2025-11-22T02:41:39.000Z","date":"2025-11-20","kind":"exercise","planned":false,"acquired":true,"shares":1714,"price":83.85,"value":143718.9,"ownership":{"direct":true},"balance_after":22545.667,"source":{"system":"sec-edgar","filing":"0001104659-25-115099","document":"tm2531977-2_4seq1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1689548/000110465925115099/tm2531977-2_4seq1.xml","form_type":"4"}},{"id":991382,"issuer":{"id":3538,"kind":"organization","name":"Praxis Precision Medicines, Inc."},"owners":[{"id":45990,"kind":"person","name":"Mastrocola Lauren","position":1,"cik":"0001827639","reported_name":"Mastrocola Lauren","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Principal Accounting Officer"}}],"security":"Stock Option (Right to Buy)","published_at":"2025-11-22T02:39:47.000Z","date":"2025-11-20","kind":"exercise","planned":false,"acquired":false,"shares":5250,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F8","text":"The shares underlying this stock option vested as to 7/48ths on July 29, 2024 and the remaining shares vest in substantially equal monthly installments over the following 41 months, subject to the Reporting Person's continued service through each vesting date."}],"balance_after":11376,"derivative":{"exercise_price":56.94,"expiration_date":"2034-07-29","underlying":"Common Stock","underlying_shares":5250},"source":{"system":"sec-edgar","filing":"0001104659-25-115098","document":"tm2531977-1_4seq1.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":16,"url":"https://www.sec.gov/Archives/edgar/data/1689548/000110465925115098/tm2531977-1_4seq1.xml","form_type":"4"}},{"id":991381,"issuer":{"id":3538,"kind":"organization","name":"Praxis Precision Medicines, Inc."},"owners":[{"id":45990,"kind":"person","name":"Mastrocola Lauren","position":1,"cik":"0001827639","reported_name":"Mastrocola Lauren","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Principal Accounting Officer"}}],"security":"Stock Option (Right to Buy)","published_at":"2025-11-22T02:39:47.000Z","date":"2025-11-20","kind":"exercise","planned":false,"acquired":false,"shares":2351,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F7","text":"The shares underlying this stock option vested as to 25% on January 12, 2024 and the remaining shares vest in substantially equal monthly installments over the following 36 months, subject to the Reporting Person's continued service through each vesting date."}],"balance_after":981,"derivative":{"exercise_price":44.4,"expiration_date":"2033-01-12","underlying":"Common Stock","underlying_shares":2351},"source":{"system":"sec-edgar","filing":"0001104659-25-115098","document":"tm2531977-1_4seq1.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":15,"url":"https://www.sec.gov/Archives/edgar/data/1689548/000110465925115098/tm2531977-1_4seq1.xml","form_type":"4"}},{"id":991380,"issuer":{"id":3538,"kind":"organization","name":"Praxis Precision Medicines, Inc."},"owners":[{"id":45990,"kind":"person","name":"Mastrocola Lauren","position":1,"cik":"0001827639","reported_name":"Mastrocola Lauren","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Principal Accounting Officer"}}],"security":"Stock Option (Right to Buy)","published_at":"2025-11-22T02:39:47.000Z","date":"2025-11-20","kind":"exercise","planned":false,"acquired":false,"shares":207,"price":0,"value":0.0,"ownership":{"direct":true},"balance_after":0,"derivative":{"exercise_price":44.4,"exercise_date":"2023-01-12","expiration_date":"2033-01-12","underlying":"Common Stock","underlying_shares":207},"source":{"system":"sec-edgar","filing":"0001104659-25-115098","document":"tm2531977-1_4seq1.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":14,"url":"https://www.sec.gov/Archives/edgar/data/1689548/000110465925115098/tm2531977-1_4seq1.xml","form_type":"4"}},{"id":991379,"issuer":{"id":3538,"kind":"organization","name":"Praxis Precision Medicines, Inc."},"owners":[{"id":45990,"kind":"person","name":"Mastrocola Lauren","position":1,"cik":"0001827639","reported_name":"Mastrocola Lauren","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Principal Accounting Officer"}}],"security":"Stock Option (Right to Buy)","published_at":"2025-11-22T02:39:47.000Z","date":"2025-11-20","kind":"exercise","planned":false,"acquired":false,"shares":2680,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F6","text":"The shares underlying this stock option vested as to 50% on January 12, 2024 and the remaining 50% vesting over a four-year period, with 25% of such shares vesting on January 12, 2025 and the remaining vesting in substantially equal monthly installments over the following 36 months, subject to the Reporting Person's continued service through each vesting date."}],"balance_after":9320,"derivative":{"exercise_price":43.37,"expiration_date":"2034-01-12","underlying":"Common Stock","underlying_shares":2680},"source":{"system":"sec-edgar","filing":"0001104659-25-115098","document":"tm2531977-1_4seq1.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":13,"url":"https://www.sec.gov/Archives/edgar/data/1689548/000110465925115098/tm2531977-1_4seq1.xml","form_type":"4"}},{"id":991378,"issuer":{"id":3538,"kind":"organization","name":"Praxis Precision Medicines, Inc."},"owners":[{"id":45990,"kind":"person","name":"Mastrocola Lauren","position":1,"cik":"0001827639","reported_name":"Mastrocola Lauren","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Principal Accounting Officer"}}],"security":"Stock Option (Right to Buy)","published_at":"2025-11-22T02:39:47.000Z","date":"2025-11-20","kind":"exercise","planned":false,"acquired":false,"shares":1557,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F5","text":"This option was fully vested as of September 8, 2024."}],"balance_after":0,"derivative":{"exercise_price":133.65,"expiration_date":"2030-09-13","underlying":"Common Stock","underlying_shares":1557},"source":{"system":"sec-edgar","filing":"0001104659-25-115098","document":"tm2531977-1_4seq1.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":12,"url":"https://www.sec.gov/Archives/edgar/data/1689548/000110465925115098/tm2531977-1_4seq1.xml","form_type":"4"}},{"id":991377,"issuer":{"id":3538,"kind":"organization","name":"Praxis Precision Medicines, Inc."},"owners":[{"id":45990,"kind":"person","name":"Mastrocola Lauren","position":1,"cik":"0001827639","reported_name":"Mastrocola Lauren","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Principal Accounting Officer"}}],"security":"Stock Option (Right to Buy)","published_at":"2025-11-22T02:39:47.000Z","date":"2025-11-20","kind":"exercise","planned":false,"acquired":false,"shares":508,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F4","text":"This option was fully vested as of May 28, 2024."}],"balance_after":0,"derivative":{"exercise_price":83.85,"expiration_date":"2030-06-04","underlying":"Common Stock","underlying_shares":508},"source":{"system":"sec-edgar","filing":"0001104659-25-115098","document":"tm2531977-1_4seq1.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":11,"url":"https://www.sec.gov/Archives/edgar/data/1689548/000110465925115098/tm2531977-1_4seq1.xml","form_type":"4"}},{"id":991376,"issuer":{"id":3538,"kind":"organization","name":"Praxis Precision Medicines, Inc."},"owners":[{"id":45990,"kind":"person","name":"Mastrocola Lauren","position":1,"cik":"0001827639","reported_name":"Mastrocola Lauren","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Principal Accounting Officer"}}],"security":"Stock Option (Right to Buy)","published_at":"2025-11-22T02:39:47.000Z","date":"2025-11-20","kind":"exercise","planned":false,"acquired":false,"shares":1047,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"This option was fully vested as of January 1, 2023."}],"balance_after":0,"derivative":{"exercise_price":49.5,"expiration_date":"2029-09-23","underlying":"Common Stock","underlying_shares":1047},"source":{"system":"sec-edgar","filing":"0001104659-25-115098","document":"tm2531977-1_4seq1.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":10,"url":"https://www.sec.gov/Archives/edgar/data/1689548/000110465925115098/tm2531977-1_4seq1.xml","form_type":"4"}},{"id":991375,"issuer":{"id":3538,"kind":"organization","name":"Praxis Precision Medicines, Inc."},"owners":[{"id":45990,"kind":"person","name":"Mastrocola Lauren","position":1,"cik":"0001827639","reported_name":"Mastrocola Lauren","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Principal Accounting Officer"}}],"security":"Common Stock","published_at":"2025-11-22T02:39:47.000Z","date":"2025-11-20","kind":"sale","planned":false,"acquired":false,"shares":2145,"price":192.711,"value":413365.095,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The price reported is a weighted average price. The securities were sold in multiple transactions at per share prices ranging from $192.552 to $193.109. The Reporting Person undertakes to provide upon request from the SEC staff, the Issuer, or any shareholder of the Issuer, full information regarding the number of securities sold at each separate price within the range set forth in this footnote."}],"balance_after":10441.656,"source":{"system":"sec-edgar","filing":"0001104659-25-115098","document":"tm2531977-1_4seq1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":9,"url":"https://www.sec.gov/Archives/edgar/data/1689548/000110465925115098/tm2531977-1_4seq1.xml","form_type":"4"}},{"id":991374,"issuer":{"id":3538,"kind":"organization","name":"Praxis Precision Medicines, Inc."},"owners":[{"id":45990,"kind":"person","name":"Mastrocola Lauren","position":1,"cik":"0001827639","reported_name":"Mastrocola Lauren","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Principal Accounting Officer"}}],"security":"Common Stock","published_at":"2025-11-22T02:39:47.000Z","date":"2025-11-20","kind":"sale","planned":false,"acquired":false,"shares":11455,"price":191.958,"value":2198878.89,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"The price reported is a weighted average price. The securities were sold in multiple transactions at per share prices ranging from $191.500 to $192.432. The Reporting Person undertakes to provide upon request from the SEC staff, the Issuer, or any shareholder of the Issuer, full information regarding the number of securities sold at each separate price within the range set forth in this footnote."}],"balance_after":12586.656,"source":{"system":"sec-edgar","filing":"0001104659-25-115098","document":"tm2531977-1_4seq1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":8,"url":"https://www.sec.gov/Archives/edgar/data/1689548/000110465925115098/tm2531977-1_4seq1.xml","form_type":"4"}},{"id":991373,"issuer":{"id":3538,"kind":"organization","name":"Praxis Precision Medicines, Inc."},"owners":[{"id":45990,"kind":"person","name":"Mastrocola Lauren","position":1,"cik":"0001827639","reported_name":"Mastrocola Lauren","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Principal Accounting Officer"}}],"security":"Common Stock","published_at":"2025-11-22T02:39:47.000Z","date":"2025-11-20","kind":"exercise","planned":false,"acquired":true,"shares":5250,"price":56.94,"value":298935.0,"ownership":{"direct":true},"balance_after":24041.656,"source":{"system":"sec-edgar","filing":"0001104659-25-115098","document":"tm2531977-1_4seq1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":7,"url":"https://www.sec.gov/Archives/edgar/data/1689548/000110465925115098/tm2531977-1_4seq1.xml","form_type":"4"}},{"id":991372,"issuer":{"id":3538,"kind":"organization","name":"Praxis Precision Medicines, Inc."},"owners":[{"id":45990,"kind":"person","name":"Mastrocola Lauren","position":1,"cik":"0001827639","reported_name":"Mastrocola Lauren","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Principal Accounting Officer"}}],"security":"Common Stock","published_at":"2025-11-22T02:39:47.000Z","date":"2025-11-20","kind":"exercise","planned":false,"acquired":true,"shares":2351,"price":44.4,"value":104384.4,"ownership":{"direct":true},"balance_after":18791.656,"source":{"system":"sec-edgar","filing":"0001104659-25-115098","document":"tm2531977-1_4seq1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":6,"url":"https://www.sec.gov/Archives/edgar/data/1689548/000110465925115098/tm2531977-1_4seq1.xml","form_type":"4"}},{"id":991371,"issuer":{"id":3538,"kind":"organization","name":"Praxis Precision Medicines, Inc."},"owners":[{"id":45990,"kind":"person","name":"Mastrocola Lauren","position":1,"cik":"0001827639","reported_name":"Mastrocola Lauren","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Principal Accounting Officer"}}],"security":"Common Stock","published_at":"2025-11-22T02:39:47.000Z","date":"2025-11-20","kind":"exercise","planned":false,"acquired":true,"shares":207,"price":44.4,"value":9190.8,"ownership":{"direct":true},"balance_after":16440.656,"source":{"system":"sec-edgar","filing":"0001104659-25-115098","document":"tm2531977-1_4seq1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/1689548/000110465925115098/tm2531977-1_4seq1.xml","form_type":"4"}},{"id":991370,"issuer":{"id":3538,"kind":"organization","name":"Praxis Precision Medicines, Inc."},"owners":[{"id":45990,"kind":"person","name":"Mastrocola Lauren","position":1,"cik":"0001827639","reported_name":"Mastrocola Lauren","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Principal Accounting Officer"}}],"security":"Common Stock","published_at":"2025-11-22T02:39:47.000Z","date":"2025-11-20","kind":"exercise","planned":false,"acquired":true,"shares":2680,"price":43.37,"value":116231.6,"ownership":{"direct":true},"balance_after":16233.656,"source":{"system":"sec-edgar","filing":"0001104659-25-115098","document":"tm2531977-1_4seq1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1689548/000110465925115098/tm2531977-1_4seq1.xml","form_type":"4"}},{"id":991369,"issuer":{"id":3538,"kind":"organization","name":"Praxis Precision Medicines, Inc."},"owners":[{"id":45990,"kind":"person","name":"Mastrocola Lauren","position":1,"cik":"0001827639","reported_name":"Mastrocola Lauren","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Principal Accounting Officer"}}],"security":"Common Stock","published_at":"2025-11-22T02:39:47.000Z","date":"2025-11-20","kind":"exercise","planned":false,"acquired":true,"shares":1557,"price":133.65,"value":208093.05,"ownership":{"direct":true},"balance_after":13553.656,"source":{"system":"sec-edgar","filing":"0001104659-25-115098","document":"tm2531977-1_4seq1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1689548/000110465925115098/tm2531977-1_4seq1.xml","form_type":"4"}},{"id":991368,"issuer":{"id":3538,"kind":"organization","name":"Praxis Precision Medicines, Inc."},"owners":[{"id":45990,"kind":"person","name":"Mastrocola Lauren","position":1,"cik":"0001827639","reported_name":"Mastrocola Lauren","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Principal Accounting Officer"}}],"security":"Common Stock","published_at":"2025-11-22T02:39:47.000Z","date":"2025-11-20","kind":"exercise","planned":false,"acquired":true,"shares":508,"price":83.85,"value":42595.8,"ownership":{"direct":true},"balance_after":11996.656,"source":{"system":"sec-edgar","filing":"0001104659-25-115098","document":"tm2531977-1_4seq1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1689548/000110465925115098/tm2531977-1_4seq1.xml","form_type":"4"}},{"id":991367,"issuer":{"id":3538,"kind":"organization","name":"Praxis Precision Medicines, Inc."},"owners":[{"id":45990,"kind":"person","name":"Mastrocola Lauren","position":1,"cik":"0001827639","reported_name":"Mastrocola Lauren","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Principal Accounting Officer"}}],"security":"Common Stock","published_at":"2025-11-22T02:39:47.000Z","date":"2025-11-20","kind":"exercise","planned":false,"acquired":true,"shares":1047,"price":49.5,"value":51826.5,"ownership":{"direct":true},"balance_after":11488.656,"source":{"system":"sec-edgar","filing":"0001104659-25-115098","document":"tm2531977-1_4seq1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1689548/000110465925115098/tm2531977-1_4seq1.xml","form_type":"4"}}],"next_cursor":"2025-11-22T02:39:47.000000Z,991367"}